Skip to main content
OpenTrials

Clinical trial condition

Secondary Progressive Multiple Sclerosis

Explore clinical trials studying Secondary Progressive Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

42 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Secondary Progressive Multiple Sclerosis trial results

Recruiting

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

NCT07299019

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Arizona Neuroscience Research, LLC Phoenix, Arizona, United States
  • Perseverance Research Center, LLC (PRC) Scottsdale, Arizona, United States
  • Fullerton Neurology and Headache Center Fullerton, California, United States
  • Regina Berkovich MD, PhD Inc West Hollywood, California, United States
View all 37 locations
View Trial Details
Recruiting

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

NCT04047628

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • Stanford Multiple Sclerosis Center Palo Alto, California, United States
  • Rocky Mountain Multiple Sclerosis Center, University of Colorado School of Medicine Aurora, Colorado, United States
  • Northwestern University Evanston, Illinois, United States
  • University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States
View all 22 locations
View Trial Details
Active, not recruiting

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

NCT04688788

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • Danish Multiple Sclerosis Center, Rigshospitalet Glostrup Municipality, Copenhagen, Denmark
  • Department of Neurology, Aalborg University Hospital Aalborg, Denmark
  • Department of Neurology, Aarhus University Hospital Aarhus, Denmark
  • Department of Neurology, Hospital of South West Jutland, Esbjerg Esbjerg, Denmark
View Trial Details
Active, not recruiting

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

NCT06372145

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • The University of Alabama at Birmingham- Site Number : 8400013 Birmingham, Alabama, United States
  • ~North Central Neurology Associates, PC- Site Number : 8400009 Cullman, Alabama, United States
  • Center for Neurology and Spine- Site Number : 8400089 Phoenix, Arizona, United States
  • Collaborative Neuroscience Research- Site Number : 8400045 Los Alamitos, California, United States
View all 352 locations
View Trial Details
Active, not recruiting

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

NCT06292923

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Yale North Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Massachusetts Worcester, Massachusetts, United States
View Trial Details
Completed

Novel Imaging Markers in SPMS

NCT05357833

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • University of Utah Health Imaging and Neurosciences Center Salt Lake City, Utah, United States
View Trial Details

Related conditions